Process analytical technique (PAT) miniaturization for monoclonal antibody aggregate detection in continuous downstream processing

The transition to continuous biomanufacturing is considered the next step to reduce costs and improve process robustness in the biopharmaceutical industry, while also improving productivity and product quality. The platform production process for monoclonal antibodies (mAbs) is eligible for continuous processing to lower manufacturing costs...

Multidimensional Crude Feedstock Profiling

The efficacy and safety of biopharmaceutical products, combined with their ability to address previously untreated conditions, has made the biopharmaceutical field the fastest growing part of the industry. Due to their unique properties, monoclonal antibodies (mAbs) and therapeutic enzymes represent the most used macromolecules for...